In our pursuit of personalized response prediction for glioblastoma patients undergoing PD1 blockade, we employed a RandomForestClassifier trained on a dataset enriched with features identified as differentially expressed between progressors and non-progressors post PD1 blockade (Figure 3 and Figure 4). The gene discussed is PDCD1; the disease is glioblastoma.